What is the purpose of this trial?
The purpose of the study is to collect information on patients who have been diagnosed with transthyretin-associated amyloidosis who carry a mutation in the gene that could lead to this disease.
Ages: 18 years and older
Pfizer Inc., U.S. Pharmaceuticals Group
Start Date: 06/04/2014
End Date: 06/30/2021
Last Updated: 02/22/2018
Study HIC#: 1306012239